Postmenopausal estrogen replacement therapy in the patient with breast carcinoma.
Cyr
M G
MG
Division of General Internal Medicine, Rhode Island Hospital, USA.
D001943:Breast Neoplasms / Q000139:chemically induced / Q000503:physiopathology*; D000075202:Contraindications; D015914:Estrogen Replacement Therapy; D004967:Estrogens / Q000502:physiology; D005260:Female; D006801:Humans; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000139:chemically induced; D009376:Neoplasms, Hormone-Dependent / Q000503:physiopathology; D015663:Osteoporosis, Postmenopausal / Q000517:prevention & control*; D011374:Progesterone / Q000502:physiology; D012307:Risk Factors; D016896:Treatment Outcome
D004967:Estrogens; D011374:Progesterone